In the last trading session, 5.01 million Canopy Growth Corporation (NASDAQ:CGC) shares changed hands as the company’s beta touched 0.88. With the company’s per share price at $1.10 changed hands at $0.05 or 4.76% during last session, the market valuation stood at $171.82M. CGC’s last price was a discount, traded about -1256.36% off its 52-week high of $14.92. The share price had its 52-week low at $1.05, which suggests the last value was 4.55% up since then. When we look at Canopy Growth Corporation’s average trading volume, we note the 10-day average is 7.19 million shares, with the 3-month average coming to 7.66 million.
Analysts gave the Canopy Growth Corporation (CGC) stock a consensus recommendation rating of Hold, calculated at a mean rating of 3.56. If we narrow down to specifics, the data shows that 1 out of 4 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 2 recommended CGC as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight. Canopy Growth Corporation’s EPS for the current quarter is expected to be -0.2.
Canopy Growth Corporation (NASDAQ:CGC) trade information
Instantly CGC was in green as seen at the end of in last trading. With action -5.98%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -59.85%, with the 5-day performance at -5.98% in the red. However, in the 30-day time frame, Canopy Growth Corporation (NASDAQ:CGC) is -38.55% down. Looking at the short shares, we see there were 13.82 million shares sold at short interest cover period of 1.36 days.
The consensus price target for the stock as assigned by Wall Street analysts is 11.02, meaning bulls need an upside of 90.02% from its current market value. According to analyst projections, CGC’s forecast low is 8 with 27.85116355 as the target high. To hit the forecast high, the stock’s price needs a -2431.92% plunge from its current level, while the stock would need to soar -627.27% for it to hit the projected low.
Canopy Growth Corporation (CGC) estimates and forecasts
Year-over-year growth is forecast to reach -19.69% down from the last financial year.
Consensus estimates given by 6 financial analysts project the company’s revenue in the current quarter to hit an average of 71.84M. 5 analysts are of the opinion that Canopy Growth Corporation’s revenue for the current quarter will be 72.15M. The company’s revenue for the corresponding quarters a year ago was 83.15M and 66.21M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at -13.61%. The estimates for the next quarter sales put growth at 8.96%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 20.88%. The 2025 estimates are for Canopy Growth Corporation earnings to increase by 49.04%, but the outlook for the next 5-year period is at 58.68% per year.
CGC Dividends
Canopy Growth Corporation is expected to release its next quarterly earnings report on 2025-Feb-06.
Canopy Growth Corporation (NASDAQ:CGC)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 0.14% of Canopy Growth Corporation shares while 6.27% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 6.28%. There are 6.27% institutions holding the Canopy Growth Corporation stock share, with SUSQUEHANNA INTERNATIONAL GROUP, LLP the top institutional holder. As of 2024-06-30, the company held 4.4929% of the shares, roughly 3.56 million CGC shares worth $22.96 million.
TOROSO INVESTMENTS, LLC holds the second largest percentage of outstanding shares, with 2.7153% or 2.15 million shares worth $13.88 million as of 2024-06-30.
Among Mutual Funds, the top two as of Dec 31, 2024 were Amplify ETF Tr-Amplify Alternative Harvest ETF and AdvisorShares Trust-AdvisorShares Pure Cannabis ETF . With 2.26 shares estimated at $2.49 million under it, the former controlled 1.43% of total outstanding shares. On the other hand, AdvisorShares Trust-AdvisorShares Pure Cannabis ETF held about 0.06% of the shares, roughly 91.46 shares worth around $0.1 million.
